Summary
Disturbances of the dopamine system are involved in the pathogenesis of idiopathic Parkinson's disease (PD). Although genetic factors may play a role in the etiology of PD, there is little direct evidence implicating a specific gene. We conducted a study to test the hypothesis that allelic variations of the dopamine receptors (D2, D3, D4) and the dopamine transporter (DAT) contribute to the susceptibility to PD. Association analyses of 70 Japanese PD patients and the same number of age-matched controls did not reveal any association between alleles of the D2, D3 or D4 receptor genes or the DAT gene and PD. Thus, our results suggest that factor(s) other than allelic variations of these key proteins in the dopamine system contribute to the susceptibility to PD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992) Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339: 1017–1018
Calne DB, Langston JW, (1983) Aetiology of Parkinson's disease. Lancet ii: 1457–1459
Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, Blum K, Noble EP, Kranzler HR, O'Malley S, Hamer DH, Whitsitt F, Rao P, DeLisi LE, Virkkunen M, Linnoila M, Goldman D, Gershon ES (1994) No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia: analysis using denaturing gradient gel electrophoresis. JAMA 271: 204–208
Gingrich JA, Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Ann Rev Neurosci 16: 299–321
Guttman M (1992) Dopamine receptors in Parkinson's disease. Neurol Clin 10: 377–386
Higuchi S, Muramatsu T, Murayama M, Hayashida M (1994) Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. Biochem Biophys Res Commun 204: 1199–1205
Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K Kondo T, Mizuno Y, Ozawa T (1990) Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 170: 1044–1048
Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M (1993) A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys). Biochem Biophys Res Commun 196: 1369–1375
Kirkwood BR (1994) Essentials of medical statistics. Oxford Blackwell Scientific Publications, London
Kopin IJ (1993) Parkinson's disease: past, present, and future. Neuropsychopharmacol 9: 1–12
Kurth JH, Kurth MC, Poduslo SE Schwankhaus JD (1993) Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 33: 368–372
Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jonsson E, Sedvall G, Schwartz JC (1992) Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiat Genet 2: 249–256
Muller U, Graeber MB, Haberhausen G, Kohler A (1994) Molecular basis and diagnosis of neurogenetic disorders. J Neurol Sci 124: 119–140
Muramatsu T, Higuchi S, Murayama M, Hayashida M (1995) Dopamine D4 receptor polymorphism and alcoholism. J Med Genet (in press)
Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H (1994) No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms. Am J Med Genet 54: 361–364
Nothen MM, Clchon S, Hemmer S, Hebebrand J, Remschmidt H, Lehmkuhl G Poustka F, Schmidt M, Catalano M, Fimmers R, Korner J, Rietschel M, Propping P (1994) Human dopamine D4 receptor gene: frequent occurrence of null allele and observation of homozygosity. Hum Mol Genet 3: 2207–2212
Ozawa T, Tanaka M, Ino H, Ohno K, Sano T, Wada Y, Yoneda M, Tanno Y, Miyatake T, Tanaka T, Itoyama S, Ikebe S, Hattori N, Mizuno Y (1991) Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun 176: 938–946
Sano A, Kondoh K, Kakimoto Y, Kondo I (1993) A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91: 405–406
Seeman P, Niznik HB (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 4: 2737–2744
Seeman P, Van Tol HHM (1993) Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 6: 602–608
Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R, Watts RL, Juncos JL, Hansen LA, Crain BJ, Fayad M, Reckord CL, Wallacw DC (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171–184
Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 339: 1375–1377
Sobell JT, Heston LL, Sommer SS (1992) Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics 12: 1–6
Stern MB, Gur RC, Saykin AJ, Hurtig HI (1986) Dementia of Parkinson's disease and Alzheimer's disease. J Am Geriatr Soc 34: 475–478
Uhl GR, Kitayama S (1993) A cloned dopamine transporter: potential insights into Parkinson's disease pathogenesis. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Advances in neurology, vol 60. Raven Press, New York, pp 321–324
Van Tol HHM, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358: 149–152
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays and VNTR. Genomis 14: 1104–1106
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Higuchi, S., Muramatsu, T., Arai, H. et al. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease. J Neural Transm Gen Sect 10, 107–113 (1995). https://doi.org/10.1007/BF02251226
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02251226